Tech Company Acquirers
Amicus Therapeutics
Wondering who was acquired by Amicus Therapeutics? Scioderm did a deal with this ambitious biopharmaceutical company.
Company Overview
Company Name
Amicus Therapeutics
Company Status
Publicly-held
Industry
Biopharmaceutical
Acquisitions
Contact Information
Mailing Address
1 Cedar Brook Dr.
Cranbury, NJ 08512
USA
Cranbury, NJ 08512
USA
Phone
Website
Email Address
Company Background Information
Overview
Amicus Therapeutics (Nasdaq:FOLD) is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases. The Company has a robust development pipeline of treatments for a range of human genetic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/31/2015
Acquisitions By Amicus Therapeutics
Date
Company
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Crowley
Chief Medical Officer
Jay Barth
Chief Operating Officer
Bradley Campbell
Chief Scientific Officer
Hung Do
Vice President
Jeffrey Castelli
VP - Finance
Daphne Quimi
Browse more tech company acquirers:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs